CareCloud (NASDAQ:CCLD) Issues FY 2026 Earnings Guidance

CareCloud (NASDAQ:CCLD) updated its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 0.200-0.230 for the period, compared to the consensus EPS estimate of 0.370. The company issued revenue guidance of $128.0 million-$132.0 million, compared to the consensus revenue estimate of $131.0 million.

Wall Street Analysts Forecast Growth

CCLD has been the subject of several research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of CareCloud in a research note on Wednesday, June 24th. Wall Street Zen raised CareCloud from a “hold” rating to a “buy” rating in a research note on Saturday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $3.25.

CareCloud Stock Up 13.4%

CCLD traded up $0.31 during trading on Friday, reaching $2.63. 455,963 shares of the stock traded hands, compared to its average volume of 332,481. The stock’s 50-day moving average is $2.30 and its 200 day moving average is $2.62. CareCloud has a 12 month low of $2.03 and a 12 month high of $4.01. The stock has a market capitalization of $111.75 million, a PE ratio of 37.57 and a beta of 1.51.

CareCloud (NASDAQ:CCLD) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.04. The company had revenue of $31.88 million for the quarter, compared to the consensus estimate of $31.85 million. CareCloud had a return on equity of 22.31% and a net margin of 6.21%.CareCloud has set its FY 2026 guidance at 0.200-0.230 EPS. As a group, equities research analysts anticipate that CareCloud will post 0.36 EPS for the current year.

Hedge Funds Weigh In On CareCloud

Institutional investors have recently made changes to their positions in the stock. Essex Investment Management Co. LLC bought a new stake in CareCloud in the 4th quarter valued at about $2,000,000. Renaissance Technologies LLC increased its position in shares of CareCloud by 96.1% during the fourth quarter. Renaissance Technologies LLC now owns 446,030 shares of the company’s stock worth $1,302,000 after acquiring an additional 218,530 shares in the last quarter. Bridgeway Capital Management LLC increased its holdings in CareCloud by 18.3% during the 4th quarter. Bridgeway Capital Management LLC now owns 380,823 shares of the company’s stock worth $1,112,000 after purchasing an additional 58,805 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of CareCloud by 235.4% in the second quarter. Geode Capital Management LLC now owns 359,486 shares of the company’s stock worth $848,000 after purchasing an additional 252,299 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of CareCloud by 127.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 252,132 shares of the company’s stock valued at $736,000 after buying an additional 141,343 shares during the last quarter. Institutional investors and hedge funds own 10.16% of the company’s stock.

About CareCloud

CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.